Uterine Fibroids Market, Global Outlook and Forecast 2022-2028

March 2022 | 108 pages | ID: UD1BA57A48D5EN
Market Monitor Global

Abstracts

Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.

This report contains market size and forecasts of Uterine Fibroids in Global, including the following market information:

Global Uterine Fibroids Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Uterine Fibroids market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-Hormonal Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Uterine Fibroids include Boston Scientific, Cooper Surgical, C.R. Bard, F. Hoffmann-La Roche, GE Healthcare, Karl Storz Endoscopy, Richard Wolf Medical Instruments, Siemens Medical Solutions and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uterine Fibroids companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Uterine Fibroids Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Uterine Fibroids Market Segment Percentages, by Type, 2021 (%)

• Non-Hormonal Treatment
• Hormonal Treatment

Global Uterine Fibroids Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Uterine Fibroids Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

Global Uterine Fibroids Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Uterine Fibroids Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Uterine Fibroids revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Uterine Fibroids revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boston Scientific
• Cooper Surgical
• C.R. Bard
• F. Hoffmann-La Roche
• GE Healthcare
• Karl Storz Endoscopy
• Richard Wolf Medical Instruments
• Siemens Medical Solutions
• AbbVie
• AstraZeneca
• Bayer
• Eli Lilly
• GlaxoSmithKline Pharmaceuticals
• Pfizer
• Johnson & Johnson
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Uterine Fibroids Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Uterine Fibroids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL UTERINE FIBROIDS OVERALL MARKET SIZE

2.1 Global Uterine Fibroids Market Size: 2021 VS 2028
2.2 Global Uterine Fibroids Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Uterine Fibroids Players in Global Market
3.2 Top Global Uterine Fibroids Companies Ranked by Revenue
3.3 Global Uterine Fibroids Revenue by Companies
3.4 Top 3 and Top 5 Uterine Fibroids Companies in Global Market, by Revenue in 2021
3.5 Global Companies Uterine Fibroids Product Type
3.6 Tier 1, Tier 2 and Tier 3 Uterine Fibroids Players in Global Market
  3.6.1 List of Global Tier 1 Uterine Fibroids Companies
  3.6.2 List of Global Tier 2 and Tier 3 Uterine Fibroids Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Uterine Fibroids Market Size Markets, 2021 & 2028
  4.1.2 Non-Hormonal Treatment
  4.1.3 Hormonal Treatment
4.2 By Type - Global Uterine Fibroids Revenue & Forecasts
  4.2.1 By Type - Global Uterine Fibroids Revenue, 2017-2022
  4.2.2 By Type - Global Uterine Fibroids Revenue, 2023-2028
  4.2.3 By Type - Global Uterine Fibroids Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Uterine Fibroids Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Centers
  5.1.5 Others
5.2 By Application - Global Uterine Fibroids Revenue & Forecasts
  5.2.1 By Application - Global Uterine Fibroids Revenue, 2017-2022
  5.2.2 By Application - Global Uterine Fibroids Revenue, 2023-2028
  5.2.3 By Application - Global Uterine Fibroids Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Uterine Fibroids Market Size, 2021 & 2028
6.2 By Region - Global Uterine Fibroids Revenue & Forecasts
  6.2.1 By Region - Global Uterine Fibroids Revenue, 2017-2022
  6.2.2 By Region - Global Uterine Fibroids Revenue, 2023-2028
  6.2.3 By Region - Global Uterine Fibroids Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Uterine Fibroids Revenue, 2017-2028
  6.3.2 US Uterine Fibroids Market Size, 2017-2028
  6.3.3 Canada Uterine Fibroids Market Size, 2017-2028
  6.3.4 Mexico Uterine Fibroids Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Uterine Fibroids Revenue, 2017-2028
  6.4.2 Germany Uterine Fibroids Market Size, 2017-2028
  6.4.3 France Uterine Fibroids Market Size, 2017-2028
  6.4.4 U.K. Uterine Fibroids Market Size, 2017-2028
  6.4.5 Italy Uterine Fibroids Market Size, 2017-2028
  6.4.6 Russia Uterine Fibroids Market Size, 2017-2028
  6.4.7 Nordic Countries Uterine Fibroids Market Size, 2017-2028
  6.4.8 Benelux Uterine Fibroids Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Uterine Fibroids Revenue, 2017-2028
  6.5.2 China Uterine Fibroids Market Size, 2017-2028
  6.5.3 Japan Uterine Fibroids Market Size, 2017-2028
  6.5.4 South Korea Uterine Fibroids Market Size, 2017-2028
  6.5.5 Southeast Asia Uterine Fibroids Market Size, 2017-2028
  6.5.6 India Uterine Fibroids Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Uterine Fibroids Revenue, 2017-2028
  6.6.2 Brazil Uterine Fibroids Market Size, 2017-2028
  6.6.3 Argentina Uterine Fibroids Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Uterine Fibroids Revenue, 2017-2028
  6.7.2 Turkey Uterine Fibroids Market Size, 2017-2028
  6.7.3 Israel Uterine Fibroids Market Size, 2017-2028
  6.7.4 Saudi Arabia Uterine Fibroids Market Size, 2017-2028
  6.7.5 UAE Uterine Fibroids Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Boston Scientific
  7.1.1 Boston Scientific Corporate Summary
  7.1.2 Boston Scientific Business Overview
  7.1.3 Boston Scientific Uterine Fibroids Major Product Offerings
  7.1.4 Boston Scientific Uterine Fibroids Revenue in Global Market (2017-2022)
  7.1.5 Boston Scientific Key News
7.2 Cooper Surgical
  7.2.1 Cooper Surgical Corporate Summary
  7.2.2 Cooper Surgical Business Overview
  7.2.3 Cooper Surgical Uterine Fibroids Major Product Offerings
  7.2.4 Cooper Surgical Uterine Fibroids Revenue in Global Market (2017-2022)
  7.2.5 Cooper Surgical Key News
7.3 C.R. Bard
  7.3.1 C.R. Bard Corporate Summary
  7.3.2 C.R. Bard Business Overview
  7.3.3 C.R. Bard Uterine Fibroids Major Product Offerings
  7.3.4 C.R. Bard Uterine Fibroids Revenue in Global Market (2017-2022)
  7.3.5 C.R. Bard Key News
7.4 F. Hoffmann-La Roche
  7.4.1 F. Hoffmann-La Roche Corporate Summary
  7.4.2 F. Hoffmann-La Roche Business Overview
  7.4.3 F. Hoffmann-La Roche Uterine Fibroids Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Uterine Fibroids Revenue in Global Market (2017-2022)
  7.4.5 F. Hoffmann-La Roche Key News
7.5 GE Healthcare
  7.5.1 GE Healthcare Corporate Summary
  7.5.2 GE Healthcare Business Overview
  7.5.3 GE Healthcare Uterine Fibroids Major Product Offerings
  7.5.4 GE Healthcare Uterine Fibroids Revenue in Global Market (2017-2022)
  7.5.5 GE Healthcare Key News
7.6 Karl Storz Endoscopy
  7.6.1 Karl Storz Endoscopy Corporate Summary
  7.6.2 Karl Storz Endoscopy Business Overview
  7.6.3 Karl Storz Endoscopy Uterine Fibroids Major Product Offerings
  7.6.4 Karl Storz Endoscopy Uterine Fibroids Revenue in Global Market (2017-2022)
  7.6.5 Karl Storz Endoscopy Key News
7.7 Richard Wolf Medical Instruments
  7.7.1 Richard Wolf Medical Instruments Corporate Summary
  7.7.2 Richard Wolf Medical Instruments Business Overview
  7.7.3 Richard Wolf Medical Instruments Uterine Fibroids Major Product Offerings
  7.7.4 Richard Wolf Medical Instruments Uterine Fibroids Revenue in Global Market (2017-2022)
  7.7.5 Richard Wolf Medical Instruments Key News
7.8 Siemens Medical Solutions
  7.8.1 Siemens Medical Solutions Corporate Summary
  7.8.2 Siemens Medical Solutions Business Overview
  7.8.3 Siemens Medical Solutions Uterine Fibroids Major Product Offerings
  7.8.4 Siemens Medical Solutions Uterine Fibroids Revenue in Global Market (2017-2022)
  7.8.5 Siemens Medical Solutions Key News
7.9 AbbVie
  7.9.1 AbbVie Corporate Summary
  7.9.2 AbbVie Business Overview
  7.9.3 AbbVie Uterine Fibroids Major Product Offerings
  7.9.4 AbbVie Uterine Fibroids Revenue in Global Market (2017-2022)
  7.9.5 AbbVie Key News
7.10 AstraZeneca
  7.10.1 AstraZeneca Corporate Summary
  7.10.2 AstraZeneca Business Overview
  7.10.3 AstraZeneca Uterine Fibroids Major Product Offerings
  7.10.4 AstraZeneca Uterine Fibroids Revenue in Global Market (2017-2022)
  7.10.5 AstraZeneca Key News
7.11 Bayer
  7.11.1 Bayer Corporate Summary
  7.11.2 Bayer Business Overview
  7.11.3 Bayer Uterine Fibroids Major Product Offerings
  7.11.4 Bayer Uterine Fibroids Revenue in Global Market (2017-2022)
  7.11.5 Bayer Key News
7.12 Eli Lilly
  7.12.1 Eli Lilly Corporate Summary
  7.12.2 Eli Lilly Business Overview
  7.12.3 Eli Lilly Uterine Fibroids Major Product Offerings
  7.12.4 Eli Lilly Uterine Fibroids Revenue in Global Market (2017-2022)
  7.12.5 Eli Lilly Key News
7.13 GlaxoSmithKline Pharmaceuticals
  7.13.1 GlaxoSmithKline Pharmaceuticals Corporate Summary
  7.13.2 GlaxoSmithKline Pharmaceuticals Business Overview
  7.13.3 GlaxoSmithKline Pharmaceuticals Uterine Fibroids Major Product Offerings
  7.13.4 GlaxoSmithKline Pharmaceuticals Uterine Fibroids Revenue in Global Market (2017-2022)
  7.13.5 GlaxoSmithKline Pharmaceuticals Key News
7.14 Pfizer
  7.14.1 Pfizer Corporate Summary
  7.14.2 Pfizer Business Overview
  7.14.3 Pfizer Uterine Fibroids Major Product Offerings
  7.14.4 Pfizer Uterine Fibroids Revenue in Global Market (2017-2022)
  7.14.5 Pfizer Key News
7.15 Johnson & Johnson
  7.15.1 Johnson & Johnson Corporate Summary
  7.15.2 Johnson & Johnson Business Overview
  7.15.3 Johnson & Johnson Uterine Fibroids Major Product Offerings
  7.15.4 Johnson & Johnson Uterine Fibroids Revenue in Global Market (2017-2022)
  7.15.5 Johnson & Johnson Key News
7.16 Novartis
  7.16.1 Novartis Corporate Summary
  7.16.2 Novartis Business Overview
  7.16.3 Novartis Uterine Fibroids Major Product Offerings
  7.16.4 Novartis Uterine Fibroids Revenue in Global Market (2017-2022)
  7.16.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Uterine Fibroids Market Opportunities & Trends in Global Market
Table 2. Uterine Fibroids Market Drivers in Global Market
Table 3. Uterine Fibroids Market Restraints in Global Market
Table 4. Key Players of Uterine Fibroids in Global Market
Table 5. Top Uterine Fibroids Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Uterine Fibroids Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Uterine Fibroids Revenue Share by Companies, 2017-2022
Table 8. Global Companies Uterine Fibroids Product Type
Table 9. List of Global Tier 1 Uterine Fibroids Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Uterine Fibroids Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Uterine Fibroids Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Uterine Fibroids Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Uterine Fibroids Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Uterine Fibroids Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Uterine Fibroids Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Uterine Fibroids Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Uterine Fibroids Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Uterine Fibroids Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Uterine Fibroids Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Uterine Fibroids Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Uterine Fibroids Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Uterine Fibroids Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Uterine Fibroids Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Uterine Fibroids Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Uterine Fibroids Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Uterine Fibroids Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Uterine Fibroids Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Uterine Fibroids Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Uterine Fibroids Revenue, (US$, Mn), 2023-2028
Table 30. Boston Scientific Corporate Summary
Table 31. Boston Scientific Uterine Fibroids Product Offerings
Table 32. Boston Scientific Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 33. Cooper Surgical Corporate Summary
Table 34. Cooper Surgical Uterine Fibroids Product Offerings
Table 35. Cooper Surgical Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 36. C.R. Bard Corporate Summary
Table 37. C.R. Bard Uterine Fibroids Product Offerings
Table 38. C.R. Bard Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Corporate Summary
Table 40. F. Hoffmann-La Roche Uterine Fibroids Product Offerings
Table 41. F. Hoffmann-La Roche Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 42. GE Healthcare Corporate Summary
Table 43. GE Healthcare Uterine Fibroids Product Offerings
Table 44. GE Healthcare Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 45. Karl Storz Endoscopy Corporate Summary
Table 46. Karl Storz Endoscopy Uterine Fibroids Product Offerings
Table 47. Karl Storz Endoscopy Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 48. Richard Wolf Medical Instruments Corporate Summary
Table 49. Richard Wolf Medical Instruments Uterine Fibroids Product Offerings
Table 50. Richard Wolf Medical Instruments Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 51. Siemens Medical Solutions Corporate Summary
Table 52. Siemens Medical Solutions Uterine Fibroids Product Offerings
Table 53. Siemens Medical Solutions Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 54. AbbVie Corporate Summary
Table 55. AbbVie Uterine Fibroids Product Offerings
Table 56. AbbVie Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Uterine Fibroids Product Offerings
Table 59. AstraZeneca Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Uterine Fibroids Product Offerings
Table 62. Bayer Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 63. Eli Lilly Corporate Summary
Table 64. Eli Lilly Uterine Fibroids Product Offerings
Table 65. Eli Lilly Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 66. GlaxoSmithKline Pharmaceuticals Corporate Summary
Table 67. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Product Offerings
Table 68. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 69. Pfizer Corporate Summary
Table 70. Pfizer Uterine Fibroids Product Offerings
Table 71. Pfizer Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 72. Johnson & Johnson Corporate Summary
Table 73. Johnson & Johnson Uterine Fibroids Product Offerings
Table 74. Johnson & Johnson Uterine Fibroids Revenue (US$, Mn), (2017-2022)
Table 75. Novartis Corporate Summary
Table 76. Novartis Uterine Fibroids Product Offerings
Table 77. Novartis Uterine Fibroids Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Uterine Fibroids Segment by Type in 2021
Figure 2. Uterine Fibroids Segment by Application in 2021
Figure 3. Global Uterine Fibroids Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Uterine Fibroids Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Uterine Fibroids Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Uterine Fibroids Revenue in 2021
Figure 8. By Type - Global Uterine Fibroids Revenue Market Share, 2017-2028
Figure 9. By Application - Global Uterine Fibroids Revenue Market Share, 2017-2028
Figure 10. By Region - Global Uterine Fibroids Revenue Market Share, 2017-2028
Figure 11. By Country - North America Uterine Fibroids Revenue Market Share, 2017-2028
Figure 12. US Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Uterine Fibroids Revenue Market Share, 2017-2028
Figure 16. Germany Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 17. France Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Uterine Fibroids Revenue Market Share, 2017-2028
Figure 24. China Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 28. India Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Uterine Fibroids Revenue Market Share, 2017-2028
Figure 30. Brazil Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Uterine Fibroids Revenue Market Share, 2017-2028
Figure 33. Turkey Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Uterine Fibroids Revenue, (US$, Mn), 2017-2028
Figure 37. Boston Scientific Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cooper Surgical Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. C.R. Bard Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GE Healthcare Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Karl Storz Endoscopy Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Richard Wolf Medical Instruments Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Siemens Medical Solutions Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AbbVie Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AstraZeneca Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Eli Lilly Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pfizer Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Johnson & Johnson Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novartis Uterine Fibroids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)